Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_assertion type Assertion NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_head.
- NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_assertion description "[Patients with neuroblastoma who were homozygous for the risk alleles at 6p22 were more likely to have metastatic (stage 4) disease (P=0.02), amplification of the MYCN oncogene in the tumor cells (P=0.006), and disease relapse (P=0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_provenance.
- NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_assertion evidence source_evidence_literature NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_provenance.
- NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_assertion SIO_000772 18463370 NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_provenance.
- NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_assertion wasDerivedFrom befree-2016 NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_provenance.
- NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_assertion wasGeneratedBy ECO_0000203 NP669781.RASukDdvEyma_fs8UiBM33T1ocszRBtvbkQGWqKNdnVlY130_provenance.